These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31466847)

  • 1. The Impact of Basal Septal Hypertrophy on Outcomes after Transcatheter Aortic Valve Replacement.
    Kiefer NJ; Salber GC; Burke GM; Chang JD; Guibone KA; Popma JJ; Hahn RT; Pinto DS; Strom JB
    J Am Soc Echocardiogr; 2019 Nov; 32(11):1416-1425. PubMed ID: 31466847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical as Opposed to Transcatheter Aortic Valve Replacement Improves Basal Interventricular Septal Hypertrophy.
    Yoshitani H; Isotani A; Song JK; Shirai S; Umeda H; Jang JY; Onoue T; Toki M; Sun BJ; Kim DH; Kagiyama N; Hayashida A; Song JM; Eto M; Nishimura Y; Ando K; Hanyu M; Yoshida K; Levine RA; Otsuji Y
    Circ J; 2018 Oct; 82(11):2887-2895. PubMed ID: 30135322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve.
    Oestreich BA; Mbai M; Gurevich S; Nijjar PS; Adabag S; Bertog S; Kelly R; Garcia S
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):626-631. PubMed ID: 29352699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement Recipients.
    Fischer Q; Himbert D; Webb JG; Eltchaninoff H; Muñoz-García AJ; Tamburino C; Nombela-Franco L; Nietlispach F; Moris C; Ruel M; Dager AE; Serra V; Cheema AN; Amat-Santos IJ; de Brito FS; Ribeiro H; Abizaid A; Sarmento-Leite R; Dumont E; Barbanti M; Durand E; Alonso Briales JH; Bouleti C; Immè S; Maisano F; Del Valle R; Miguel Benitez L; García Del Blanco B; Côté M; Philippon F; Urena M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2018 Nov; 11(11):e006927. PubMed ID: 30571207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Auffret V; Webb JG; Eltchaninoff H; Muñoz-García AJ; Himbert D; Tamburino C; Nombela-Franco L; Nietlispach F; Morís C; Ruel M; Dager AE; Serra V; Cheema AN; Amat-Santos IJ; de Brito FS; Lemos PA; Abizaid A; Sarmento-Leite R; Dumont E; Barbanti M; Durand E; Alonso Briales JH; Vahanian A; Bouleti C; Immè S; Maisano F; Del Valle R; Benitez LM; García Del Blanco B; Puri R; Philippon F; Urena M; Rodés-Cabau J
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1564-1574. PubMed ID: 28734885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients.
    Sharma E; Chu AF
    J Interv Card Electrophysiol; 2018 Jan; 51(1):77-86. PubMed ID: 29260369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
    Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preprocedural and procedural variables that predict new-onset conduction disturbances after transcatheter aortic valve replacement.
    Boonyakiatwattana W; Maneesai A; Chaithiraphan V; Jakrapanichakul D; Sakiyalak P; Chunhamaneewat N; Slisatkorn W; Chotinaiwattarakul C; Pongakasira R; Wongpraparut N
    BMC Cardiovasc Disord; 2022 Mar; 22(1):135. PubMed ID: 35361124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Care of Patients With Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Replacement.
    Kassier A; Velagapudi P; Shrestha NM; Schuitema J; Gauri A; Frost J; Merhi W; Jovinge S; Chalfoun N
    Cardiovasc Revasc Med; 2022 Sep; 42():17-25. PubMed ID: 35398009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.
    Krackhardt F; Kherad B; Krisper M; Pieske B; Laule M; Tschöpe C
    Cardiol J; 2017; 24(3):250-258. PubMed ID: 28248410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
    Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
    Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.
    Gleason TG; Schindler JT; Hagberg RC; Deeb GM; Adams DH; Conte JV; Zorn GL; Hughes GC; Guo J; Popma JJ; Reardon MJ
    Ann Thorac Surg; 2018 Feb; 105(2):477-483. PubMed ID: 29100645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic determinants of LV functional improvement after transcatheter aortic valve replacement.
    Chen J; Nawaz N; Fox Z; Komlo C; Anwaruddin S; Desai N; Jagasia D; Herrmann HC; Han Y
    Catheter Cardiovasc Interv; 2016 May; 87(6):1164-72. PubMed ID: 27145743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry.
    Hokken TW; Muhemin M; Okuno T; Veulemans V; Lopes BB; Beneduce A; Vittorio R; Ooms JF; Adrichem R; Neleman T; Kardys I; Daemen J; Chieffo A; Montorfano M; Cavalcante J; Zeus T; Pilgrim T; Toggweiler S; Van Mieghem NM
    J Cardiovasc Comput Tomogr; 2022; 16(6):524-530. PubMed ID: 35872136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Clinical Outcomes of Transcatheter Aortic Valve Replacement in Left Ventricular Outflow Tract Calcification: New-Generation Device vs Early-Generation Device.
    Nomura T; Maeno Y; Yoon SH; Abramowitz Y; Israr S; Miyasaka M; Kazuno Y; Takahashi N; Kawamori H; Nakamura M; Jilaihawi H; Makkar RR
    J Invasive Cardiol; 2018 Nov; 30(11):421-427. PubMed ID: 30373952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-Existing Right Bundle Branch Block Increases Risk for Death After Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.
    Watanabe Y; Kozuma K; Hioki H; Kawashima H; Nara Y; Kataoka A; Nagura F; Nakashima M; Shirai S; Tada N; Araki M; Takagi K; Yamanaka F; Yamamoto M; Hayashida K
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2210-2216. PubMed ID: 27832846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Left Ventricle and Clinical Outcomes After Transcatheter Aortic Valve Replacement.
    Saito T; Inohara T; Yoshijima N; Yashima F; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    J Am Heart Assoc; 2021 Apr; 10(7):e019543. PubMed ID: 33749309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.